DE19906310A1 - Arzneimittel zur Behandlung von Bluthochdruck - Google Patents
Arzneimittel zur Behandlung von BluthochdruckInfo
- Publication number
- DE19906310A1 DE19906310A1 DE19906310A DE19906310A DE19906310A1 DE 19906310 A1 DE19906310 A1 DE 19906310A1 DE 19906310 A DE19906310 A DE 19906310A DE 19906310 A DE19906310 A DE 19906310A DE 19906310 A1 DE19906310 A1 DE 19906310A1
- Authority
- DE
- Germany
- Prior art keywords
- phenyl
- lower alkyl
- group
- blood pressure
- high blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (30)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19906310A DE19906310A1 (de) | 1999-02-16 | 1999-02-16 | Arzneimittel zur Behandlung von Bluthochdruck |
| ARP000100257A AR036864A1 (es) | 1999-02-16 | 2000-01-20 | Uso de compuestos de acido benzacepin-n-acetico, y procedimiento para la preparacion de dichos compuestos |
| TW089101041A TWI221770B (en) | 1999-02-16 | 2000-01-21 | Medicament for treating hypertension |
| RU2001124604/15A RU2270679C2 (ru) | 1999-02-16 | 2000-02-10 | Лекарственное средство для лечения гипертензии |
| CZ20012672A CZ301499B6 (cs) | 1999-02-16 | 2000-02-10 | Lék pro lécbu vysokého krevního tlaku |
| KR1020077001387A KR100797665B1 (ko) | 1999-02-16 | 2000-02-10 | 고혈압 치료를 위한 약제학적 조성물 |
| ES00903681T ES2238268T3 (es) | 1999-02-16 | 2000-02-10 | Medicamento para el tratamiento de la hipertension sanguinea. |
| AT00903681T ATE295174T1 (de) | 1999-02-16 | 2000-02-10 | Arzneimittel zur behandlung von bluthochdruck |
| HK02104121.2A HK1042247B (zh) | 1999-02-16 | 2000-02-10 | 苯並氮雜䓬-n-乙酸衍生物在製備治療肺高血壓的藥物中的應用 |
| PT00903681T PT1154777E (pt) | 1999-02-16 | 2000-02-10 | Medicamento para o tratamento de hipertensao arterial |
| EP00903681A EP1154777B1 (de) | 1999-02-16 | 2000-02-10 | Arzneimittel zur behandlung von bluthochdruck |
| JP2000599393A JP2002537258A (ja) | 1999-02-16 | 2000-02-10 | 高血圧の治療のための医薬 |
| DE50010284T DE50010284D1 (de) | 1999-02-16 | 2000-02-10 | Arzneimittel zur behandlung von bluthochdruck |
| CA2362273A CA2362273C (en) | 1999-02-16 | 2000-02-10 | Benzazepine-n-ethanoic acid derivatives for treating secondary hypertension |
| PL00350167A PL195283B1 (pl) | 1999-02-16 | 2000-02-10 | Zastosowanie pochodnych kwasu benzazepino-N-octowego |
| NZ514058A NZ514058A (en) | 1999-02-16 | 2000-02-10 | Medicament for treating hypertension |
| AU25476/00A AU773240C (en) | 1999-02-16 | 2000-02-10 | Medicament for treating hypertension |
| TR2001/02386T TR200102386T2 (tr) | 1999-02-16 | 2000-02-10 | Yüksek tansiyon tedavisi için ilaç. |
| SK1082-2001A SK287254B6 (sk) | 1999-02-16 | 2000-02-10 | Použitie derivátov benzazepín-N-kyseliny octovej na výrobu farmaceutických prípravkov na liečbu vysokého krvného tlaku |
| BR0008260-0A BR0008260A (pt) | 1999-02-16 | 2000-02-10 | Medicamento para tratamento de hipertensão arterial |
| KR1020017009705A KR20010101922A (ko) | 1999-02-16 | 2000-02-10 | 고혈압 치료를 위한 약제학적 조성물 |
| CNB008038236A CN1198619C (zh) | 1999-02-16 | 2000-02-10 | 苯并氮杂䓬-n-乙酸衍生物在制备治疗肺高血压的药物中的应用 |
| HU0105491A HUP0105491A3 (en) | 1999-02-16 | 2000-02-10 | Use of 3-[1-(2-aralkyl-2-carboxyethyl)-1-cyclopentanecarboxamido]-2,3,4,5-tetrahydro-2-oxo-1h-benz(b)azepine-1-acetic acid derivatives for manufacture of a medicament for treating hypertension |
| PCT/EP2000/001068 WO2000048601A1 (de) | 1999-02-16 | 2000-02-10 | Arzneimittel zur behandlung von bluthochdruck |
| DZ000029A DZ3014A1 (fr) | 1999-02-16 | 2000-02-13 | Médicaments pour le traitement de l'hypertension. |
| UA2001096336A UA63032C2 (en) | 1999-02-16 | 2000-10-02 | Drug for treating hypertension |
| ZA200105828A ZA200105828B (en) | 1999-02-16 | 2001-07-16 | Medicament for treating hypertension. |
| IL144622A IL144622A (en) | 1999-02-16 | 2001-07-30 | Medicament for treating hypertension |
| NO20013958A NO329588B1 (no) | 1999-02-16 | 2001-08-15 | Anvendelse av benzazepin-N-eddiksyrederivater til fremstilling av farmasoytiske preparater for behandling av sekundaeformer av hypertensjon |
| US09/930,186 US6482820B2 (en) | 1999-02-16 | 2001-08-16 | Pharmaceutical compositions and method for the inhibition and treatment of secondary hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19906310A DE19906310A1 (de) | 1999-02-16 | 1999-02-16 | Arzneimittel zur Behandlung von Bluthochdruck |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE19906310A1 true DE19906310A1 (de) | 2000-08-17 |
Family
ID=7897580
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19906310A Ceased DE19906310A1 (de) | 1999-02-16 | 1999-02-16 | Arzneimittel zur Behandlung von Bluthochdruck |
| DE50010284T Expired - Lifetime DE50010284D1 (de) | 1999-02-16 | 2000-02-10 | Arzneimittel zur behandlung von bluthochdruck |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE50010284T Expired - Lifetime DE50010284D1 (de) | 1999-02-16 | 2000-02-10 | Arzneimittel zur behandlung von bluthochdruck |
Country Status (28)
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19932555A1 (de) * | 1999-07-13 | 2001-01-18 | Solvay Pharm Gmbh | Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen |
| WO2001036610A1 (en) * | 1999-11-19 | 2001-05-25 | Solvay Pharmaceuticals B.V. | Human enzymes of the metalloprotease family |
| IL145684A (en) * | 2000-10-04 | 2007-06-17 | Warner Lambert Co | Medications for the treatment of pulmonary hypertension |
| AR039352A1 (es) * | 2001-05-18 | 2005-02-16 | Solvay Pharm Gmbh | Uso de un compuesto que tiene actividad inhibitoria combinada y concurrente con endopeptidasa neutra y metaloproteasa igs5. |
| CN100519561C (zh) * | 2001-09-10 | 2009-07-29 | 泰博特克药品有限公司 | 制备六氢-呋喃并[2,3-b]呋喃-3-醇的方法 |
| IL162645A0 (en) | 2002-01-16 | 2005-11-20 | Solvay Pharm Bv | solid salts benzazepine compounds and their use inthe preparation of pharmaceuticals compounds |
| AR038681A1 (es) * | 2002-02-14 | 2005-01-26 | Solvay Pharm Bv | Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua |
| WO2004062692A1 (en) * | 2003-01-13 | 2004-07-29 | Solvay Pharmaceuticals B.V. | Formulation of poorly water-soluble active substances |
| US7452875B2 (en) | 2003-09-26 | 2008-11-18 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
| US7262184B2 (en) | 2003-09-26 | 2007-08-28 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
| SA04250283B1 (ar) * | 2003-09-26 | 2008-05-26 | سولفاي فارماسيتيكالز جي أم بي أتش | مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid |
| US7427611B2 (en) | 2003-09-26 | 2008-09-23 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
| AR046454A1 (es) * | 2003-11-18 | 2005-12-07 | Solvay Pharm Gmbh | Uso de un compuesto de acido benzazepin-n-acetico, composicion farmaceutica, y procedimiento para la produccion de dicha composicion farmaceutica |
| US20050267124A1 (en) * | 2004-05-14 | 2005-12-01 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors |
| US20050267072A1 (en) * | 2004-05-14 | 2005-12-01 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction |
| US20050288272A1 (en) * | 2004-06-23 | 2005-12-29 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists |
| US7816347B2 (en) | 2004-12-15 | 2010-10-19 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors |
| US20060205625A1 (en) * | 2005-02-18 | 2006-09-14 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| US20070292503A1 (en) * | 2006-06-16 | 2007-12-20 | Gorissen Henricus R | Oral pharmaceutical composition of poorly water-soluble active substance |
| US20070299054A1 (en) * | 2006-06-22 | 2007-12-27 | Rajesh Jain | Oral pharmaceutical composition of a poorly water-soluble active agent |
| KR20170005155A (ko) * | 2008-01-31 | 2017-01-11 | 반더빌트유니버시티 | 폐의 용태에 따른 치료 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4749688A (en) * | 1986-06-20 | 1988-06-07 | Schering Corporation | Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension |
| EP0254032A3 (en) * | 1986-06-20 | 1990-09-05 | Schering Corporation | Neutral metalloendopeptidase inhibitors in the treatment of hypertension |
| CA1337400C (en) * | 1987-06-08 | 1995-10-24 | Norma G. Delaney | Inhibitors of neutral endopeptidase |
| US5087702A (en) * | 1991-01-30 | 1992-02-11 | Merck & Co., Inc. | Microbial transformation process for producing an antihypertensive product |
| US5362727A (en) * | 1993-07-26 | 1994-11-08 | Bristol-Myers Squibb | Substituted azepino[2,1-a]isoquinoline compounds |
| DE19510566A1 (de) * | 1995-03-23 | 1996-09-26 | Kali Chemie Pharma Gmbh | Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19638020A1 (de) * | 1996-09-18 | 1998-03-19 | Solvay Pharm Gmbh | Die gastrointestinale Durchblutung fördernde Arzneimittel |
-
1999
- 1999-02-16 DE DE19906310A patent/DE19906310A1/de not_active Ceased
-
2000
- 2000-01-20 AR ARP000100257A patent/AR036864A1/es unknown
- 2000-01-21 TW TW089101041A patent/TWI221770B/zh not_active IP Right Cessation
- 2000-02-10 JP JP2000599393A patent/JP2002537258A/ja active Pending
- 2000-02-10 KR KR1020077001387A patent/KR100797665B1/ko not_active Expired - Fee Related
- 2000-02-10 AU AU25476/00A patent/AU773240C/en not_active Ceased
- 2000-02-10 BR BR0008260-0A patent/BR0008260A/pt not_active Application Discontinuation
- 2000-02-10 HK HK02104121.2A patent/HK1042247B/zh not_active IP Right Cessation
- 2000-02-10 ES ES00903681T patent/ES2238268T3/es not_active Expired - Lifetime
- 2000-02-10 TR TR2001/02386T patent/TR200102386T2/xx unknown
- 2000-02-10 CN CNB008038236A patent/CN1198619C/zh not_active Expired - Fee Related
- 2000-02-10 RU RU2001124604/15A patent/RU2270679C2/ru not_active IP Right Cessation
- 2000-02-10 NZ NZ514058A patent/NZ514058A/en not_active IP Right Cessation
- 2000-02-10 CZ CZ20012672A patent/CZ301499B6/cs not_active IP Right Cessation
- 2000-02-10 HU HU0105491A patent/HUP0105491A3/hu unknown
- 2000-02-10 KR KR1020017009705A patent/KR20010101922A/ko not_active Ceased
- 2000-02-10 EP EP00903681A patent/EP1154777B1/de not_active Expired - Lifetime
- 2000-02-10 DE DE50010284T patent/DE50010284D1/de not_active Expired - Lifetime
- 2000-02-10 PT PT00903681T patent/PT1154777E/pt unknown
- 2000-02-10 AT AT00903681T patent/ATE295174T1/de active
- 2000-02-10 CA CA2362273A patent/CA2362273C/en not_active Expired - Fee Related
- 2000-02-10 SK SK1082-2001A patent/SK287254B6/sk not_active IP Right Cessation
- 2000-02-10 PL PL00350167A patent/PL195283B1/pl not_active IP Right Cessation
- 2000-02-10 WO PCT/EP2000/001068 patent/WO2000048601A1/de not_active Ceased
- 2000-02-13 DZ DZ000029A patent/DZ3014A1/xx active
- 2000-10-02 UA UA2001096336A patent/UA63032C2/uk unknown
-
2001
- 2001-07-16 ZA ZA200105828A patent/ZA200105828B/en unknown
- 2001-07-30 IL IL144622A patent/IL144622A/en not_active IP Right Cessation
- 2001-08-15 NO NO20013958A patent/NO329588B1/no not_active IP Right Cessation
- 2001-08-16 US US09/930,186 patent/US6482820B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1154777B1 (de) | Arzneimittel zur behandlung von bluthochdruck | |
| DE60131547T2 (de) | Abführende zusammensetzungen | |
| DE69602424T2 (de) | Verwendung von carbazolverbindungen zur herstellung eines arzneimittels für die behandlung von kongestivem herzversagen | |
| DE602004010531T2 (de) | Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma | |
| DE69125714T2 (de) | Zusammensetzung für die behandlung des humanen prostata adenokarzinom | |
| DE69213800T2 (de) | Oral anzuwendende magensaftstabile Arzneimittel mit gesteuerter Wirkstoffabgabe enthaltend Gallensäuren und deren Salze | |
| US4217347A (en) | Method of treating hypertension and medicaments therefor | |
| DE2523998A1 (de) | Pharmazeutische zubereitung fuer die behandlung der schizophrenie | |
| EP1509207B1 (de) | Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung | |
| EP1200095B1 (de) | Arzneimittel mit protektiver wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische substanzen | |
| DE69420776T2 (de) | Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer | |
| DE60030654T2 (de) | Verwendung von Lasofoxifen | |
| DE69131398T2 (de) | Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall | |
| EP0689837A2 (de) | Antihyperglykämisch wirksame Arzneimittel | |
| DE2507635C2 (cg-RX-API-DMAC7.html) | ||
| DE3542794A1 (de) | Antihypertensives kombinationspraeparat | |
| DE68907976T2 (de) | Verwendung eines Thromboxan-A2-Rezeptorantagonist zur Herstellung eines Arzeneimittels zur Behandlung pulmonarer Hypertonie, die durch Protamin-induzierte Neutralisation von Heparin verursacht wird. | |
| EP0601345A1 (de) | Imidazol-1-yl-Verbindung enthaltende Arzneimittel | |
| EP0471388B1 (de) | Mittel zur Behandlung der Herzinsuffizienz | |
| EP0524512B1 (de) | Antihypertensive Kombination | |
| DE69307197T2 (de) | Verwendung von 24,25-Dihydroxyvitamin-D3 zur Herstellung eines Arzneimittel zur Behandlung der Rachitis | |
| DE19911371A1 (de) | Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen | |
| DE2855306A1 (de) | Mittel zur senkung der herzfrequenz | |
| EP0331871A2 (de) | Antipsychotisch wirksames Imidazobenzodiazepin | |
| DE4001496A1 (de) | Niedrig dosierte zusammensetzung enthaltend benazepril und ein thiaziddiuretikum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8131 | Rejection |